- Amendment of commercial and regulatory milestones for $50 million of additional non-dilutive capital to support launch of Motiva Implants®…
- Amendment of commercial and regulatory milestones for $50 million of additional non-dilutive capital to support launch of Motiva Implants®…
Received Notice of Allowance from the USPTO on February 15, 2024LOS GATOS, CA / ACCESSWIRE / February 22, 2024 /…
Raises Approximately $2.6 Million in Gross ProceedsRetires $1.25 Million in Secured DebtThis corrects and replaces the headline in the release…
LONDON--(BUSINESS WIRE)--#advancedcirculatorysupport--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the quarter and full year ended…
~ Raises Approximately $2.6 Million in Gross Proceeds ~~ Retires $1.25 Million in Secured Debt ~LOS GATOS, CA / ACCESSWIRE…
Transumbilical Breast Augmentation Technique (TUBA) Reduces Risk of Breast Implant Complications and ReactionsSEATTLE, WA / ACCESSWIRE / February 14, 2024…
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,…
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,…
Company secures $22.5 million of new money in debtor-in-possession financing from existing lenders to support ongoing operations during the sale…